[July 02, 2015]

Research and Markets: PharmaSphere: North American Market Access Strategy 2015 - Strategic Analysis of the Pharmaceutical Market

Research and Markets (http://www.researchandmarkets.com/research/l696pp/pharmasphere) has announced the addition of the "PharmaSphere: North American Market Access Strategy" company profile to their offering.

The "PharmaSphere: North American Market Access Strategy" report provides a strategic analysis of the pharmaceutical market landscape in this geographic region, and the impact of the current and emerging market access strategies that the pharmaceutical industry is using for its for new and existing drugs. It discusses the regulatory requirements for pharmaceutical products in North American, key health insurance trends, recent government healthcare reforms, and general industry trends. It also describes the macroeconomic factors that impact the commercialization of new pharmaceutical products. Furthermore, it includes a geographic segmentation of the various markets in North America, including the US, Canada, and Mexico, providing an in-depth anaysis of these markets' regulatory frameworks, healthcare systems, health insurance markets, key domestic players, and strategic outlook.

Key Questions Answered

- What are the main factors influencing market access in North America?

- How do demographic trends impact market access in Canada and Mexico?

- What are the important elements of the healthcare systems in the US, Canada, and Mexico?

- How important is health technology assessment (HTA)? What are the key processes leading up to a successful HTA in North America?

- What are the different pricing and reimbursement procedures adopted by regulators in North America?

- How has recent healthcare reform legislation changed market access considerations from the perspective of regulators and pharmaceutical companies?

- How have cost-containment pressures impacted the commercialization of new pharmaceutical products?

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Market Access Policy Evolution

4 United States

5 Canada

6 Mexico

7 Benchmark Ratings

8 Outlook

9 Appendix

Companies Mentioned

• Amgen
• Ariad
• Bayer
• Biogen
• BMS
• Dendreon
• Exelixis
• Gilead
• Hospira
• J&J
• Merck
• Mylan
• Novartis
• Onyx
• Pfizer
• Roche
• Sanofi

For more information visit http://www.researchandmarkets.com/research/l696pp/pharmasphere

View source version on businesswire.com: http://www.businesswire.com/news/home/20150702005525/en/

[ Back To TMCnet.com's Homepage ]